anayamalik, Author at European Medical Journal - Page 81 of 128

U.S. Surgeries See Fewer Opioid Prescriptions

Opioid prescribing trends following outpatient surgery have seen a marked decline over the last decade, according to new U.S. claims data, signaling a nationwide shift in post-operative pain management across multiple surgical specialties.

Minor Stroke, Major Impact: Argatroban Combo Improves 90-Day Outcomes in RCT

In patients with branch atherosclerosis disease (BAD), early neurological deterioration (END) poses a significant threat to recovery, even in mild strokes.

Medical Tourism Rising: Why Are International Families Seeking Care in the U.S.?

Pediatric cancer care, medical tourism, and cross-border access to healthcare converge in a newly published 10-year review highlighting international families traveling to the United States for treatment of serious childhood malignancies and blood disorders.

School-Based Asthma Care: Dramatic Results from a 6-Year Study

Children with persistent asthma who received school-based therapy in Columbus, Ohio experienced marked improvements in asthma control and a sharp reduction in healthcare utilization, according to new research.

High Hepatitis C Cure Rate After Retreatment in People Who Inject Drugs

New data from the U.S.-based HERO Study shed light on an important question for hepatitis C virus (HCV) management: How effective is retreatment among people who inject drugs (PWID)?

Laser vs Diathermy: OA Treatment Outcomes Comparison Trial

In a randomized trial, researchers evaluated two physical therapy approaches—high-intensity laser therapy (HILT) and short-wave diathermy (SWD), each combined with exercise, for treating patients with Stage 2–3 knee osteoarthritis.

Cognitive-Behavioral Clues: Understanding of Body Dysmorphic Disorder

A new systematic review and meta-analysis sheds light on the evolving understanding of body dysmorphic disorder (BDD), presented in line with recent psychiatric research updates.

Phase II Trial Shows Clinical and Imaging Evidence of Brain Repair in MS: AAN 2025

At the American Academy of Neurology (AAN) Annual Meeting 2025, researchers presented new data from the long-term open-label extension of the Phase II VISIONARY-MS trial, reporting imaging and physiologic findings consistent with improved neuronal function and remyelination in patients with multiple sclerosis (MS).

Can Electronic Symptom Monitoring Transform Cancer Care?

Electronic patient-reported outcomes (ePROs) are increasingly seen as a promising tool to improve cancer care quality, especially for patients with metastatic disease.

Revolutionary 'Lab-in-Tube' Test Offers Rapid, Low-Cost TB Diagnosis

A fast, low-cost tuberculosis (TB) test that delivers results in under an hour from blood, saliva, or sputum samples could dramatically improve care in both well-equipped hospitals and resource-limited settings.